BCL2 and neuroblastoma: As shown in Fig. 1G, 100 nM TP-0903 treatment resulted in cleavage of PARP and caspase-3, while decreasing cellular level of anti-apoptotic Mcl-1 and Bcl-2 in both NB cells (P < 0.05 vs control).